Global Head Lice Treatment Market, By Type (Pediculosis Capitis, Pediculosis Corporis, Pediculosis Pubis, Others), Treatment (Ivermectin, Spinosad, Permethrin, Pyrethrin, Other), Route of Administration (Oral, Topical, Others), Dosage Form (Tablets, Shampoos, Lotions, Cream, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) - Industry Trends and Forecast to 2030.
Head Lice Treatment Market Analysis and Size
Head lice treatment refers to the market for products and services aimed at preventing and treating head lice infestations. It includes over-the-counter and prescription medications, shampoos, and other treatment methods to eliminate head lice and their eggs.
Data Bridge Market Research analyses that the Head lice treatment market was valued at USD 978.98 million in 2022 and is expected to reach USD 1,606.10 million by 2030, at a CAGR of 6.1% during the forecast period. "Pediculosis Capitis" dominates the type segment of the Head lice treatment market owing to the increasing prevalence of cardiac arrhythmias. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Head Lice Treatment Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Type (Pediculosis Capitis, Pediculosis Corporis, Pediculosis Pubis, Others), Treatment (Ivermectin, Spinosad, Permethrin, Pyrethrin, Other), Route of Administration (Oral, Topical, Others), Dosage Form (Tablets, Shampoos, lotions, cream, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
|
|
Market Players Covered
|
F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd.(Israel), Sanofi (France), Pfizer Inc. (U.S.), GlaxoSmithKline plc (UK), Novartis AG (Switzerland), AstraZeneca (UK), Johnson & Johnson (U.S.), Bayer AG (Germany), Sun Pharmaceutical Industries Ltd. (India), Eli Lilly and Company (U.S.), Edenbridge Pharmaceuticals, LLC (U.S.), ParaPRO LLC (U.S.), Encube Ethicals (India), GALDERMA (Switzerland), Alliance Pharmaceuticals (UK), Foamix Pharmaceuticals Ltd (U.S.), Arbor Pharmaceuticals (U.S.), Dr. Reddy's Laboratories Ltd. (India), Perrigo Company plc (Ireland).among others.
|
|
Market Opportunities
|
|
Market Definition
Head lice, called pediculosis, refers to a tiny, wingless insect that feeds, lives, and breeds on the human scalp. These insects can survive away from a human host for 10 days, and a prominent symptom of lice is intense itching in the infected area.
Head Lice Treatment Market Dynamics
Drivers
- High Prevalence of Head Lice Infestations
Head lice infestations are common, particularly among children in school settings. The widespread occurrence of head lice drives the demand for effective treatment options.
- Increasing Awareness and Education
Growing awareness campaigns, educational programs, and initiatives by healthcare organizations and schools contribute to increased awareness about head lice infestations and the importance of timely treatment, boosting the market.
- Advancements in Product Formulations
Continuous research and development efforts lead to advancements in product formulations, including new active ingredients, improved efficacy, and user-friendly application methods. These advancements drive market growth by providing innovative and more effective treatment solutions.
Opportunities
- Government initiations to support head lice treatment
The government initiatives, schemes, or funding that support and promote the innovation and development of the head lice treatment market provide growth opportunities for the market players from 2023 to 2030. Additionally, rising demand for natural and non-toxic treatment, increasing adoption of online sales channels, penetration rate, market expansion in developing countries, and increasing per capita expenditure on health care will further expand the market's growth rate in the future.
Restraints/ Challenges
- Growing Resistance to Conventional Treatments
Over time, head lice have resisted certain conventional treatments, making them less effective. This resistance poses a challenge in achieving successful treatment outcomes.
- Lack of Consensus on Treatment Protocols
The head lice treatment market varying recommendations and treatment protocols from different healthcare authorities and organizations create confusion among consumers and healthcare providers, impacting treatment decisions. Also, risk stratification and patient management among healthcare providers in developing economies, adherence to lifestyle modifications and medications, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2023-2030.
This head lice treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Head lice treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In May 2022, The Centers for Disease Control and Prevention estimate that 6 million to 12 million cases of head lice occur each year in the U.S. in children ages 3 to 11.
Global Head Lice Treatment Market Scope
The head lice treatment market is segmented on the basis of type, drugs, medication type, mode of administration, distribution channel, and end-users. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Pediculosis Capitis
- Pediculosis Corporis
- Pediculosis Pubis
- Others
Drug
- Ivermectin
- Spinosad
- Permethrin
- Pyrethrin
- Other
Medication Type
- OTC Products
- Prescription Medications
Formulation
- Lotion
- Oil
- Shampoo
Mode of Administration
- Injectable
- Oral
- Others
End-Users
- Hospitals
- Specialty Clinics
- Homecare
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Head Lice Treatment Market Regional Analysis/Insights
The head lice treatment market is analysed and market size insights and trends are provided by country, type, drugs, medication type, formulation, mode of administration, distribution channel and end user as referenced above.
The countries covered in the Head lice treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
North America dominates the Head lice treatment market due to the established healthcare system within the region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to presence of generic manufacturers in this region. Also, the development of healthcare infrastructure and large population in the region
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The head lice treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Head lice treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the head lice treatment market. The data is available for historic period 2015-2020.
Competitive Landscape and Head Lice Treatment Market Share Analysis
The head lice treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the head lice treatment market are:
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (U.S.)
- Teva Pharmaceutical Industries Ltd.(Israel)
- Sanofi (France),
- Pfizer Inc. (U.S.)
- GlaxoSmithKline plc (UK)
- Novartis AG (Switzerland)
- AstraZeneca (UK)
- Johnson & Johnson (U.S.)
- Bayer AG (Germany)
- Sun Pharmaceutical Industries Ltd. (India)
- Eli Lilly and Company (U.S.)
- Edenbridge Pharmaceuticals, LLC (U.S.)
- ParaPRO LLC (U.S.)
- Encube Ethicals (India)
- GALDERMA (Switzerland)
- Alliance Pharmaceuticals (UK)
- Foamix Pharmaceuticals Ltd (U.S.)
- Arbor Pharmaceuticals (U.S.)
- Dr. Reddy's Laboratories Ltd. (India)
- Perrigo Company plc (Ireland)
SKU-